MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 157 filers reported holding MYOKARDIA INC in Q2 2019. The put-call ratio across all filers is 2.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $9,001,000 | +16.9% | 66,022 | -17.2% | 0.01% | +7.7% |
Q2 2020 | $7,700,000 | +157.1% | 79,693 | +24.7% | 0.01% | +116.7% |
Q1 2020 | $2,995,000 | -33.9% | 63,889 | +2.8% | 0.01% | -25.0% |
Q4 2019 | $4,532,000 | +46.5% | 62,179 | +4.8% | 0.01% | +33.3% |
Q3 2019 | $3,094,000 | +5.6% | 59,327 | +1.5% | 0.01% | 0.0% |
Q2 2019 | $2,930,000 | +25.5% | 58,436 | +30.1% | 0.01% | +20.0% |
Q1 2019 | $2,334,000 | +6.4% | 44,900 | +0.0% | 0.01% | 0.0% |
Q4 2018 | $2,193,000 | +11.3% | 44,885 | +48.6% | 0.01% | +25.0% |
Q3 2018 | $1,970,000 | +35.8% | 30,209 | +3.4% | 0.00% | +33.3% |
Q2 2018 | $1,451,000 | +59.5% | 29,228 | +56.7% | 0.00% | +50.0% |
Q1 2018 | $910,000 | +15.8% | 18,649 | -0.1% | 0.00% | 0.0% |
Q4 2017 | $786,000 | -11.8% | 18,670 | -10.2% | 0.00% | 0.0% |
Q3 2017 | $891,000 | +268.2% | 20,788 | +12.4% | 0.00% | +100.0% |
Q2 2017 | $242,000 | +44.9% | 18,489 | +45.4% | 0.00% | – |
Q1 2017 | $167,000 | +8.4% | 12,716 | +7.2% | 0.00% | – |
Q4 2016 | $154,000 | – | 11,858 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 486,624 | $23,776,000 | 10.91% |
Casdin Capital, LLC | 790,000 | $38,599,000 | 6.60% |
Foresite Capital Management III, LLC | 361,441 | $17,660,000 | 5.80% |
Fernwood Investment Management, LLC | 141,511 | $6,914,000 | 4.46% |
Cormorant Asset Management, LP | 677,451 | $33,100,000 | 2.69% |
Grace Capital | 112,204 | $5,658,000 | 2.63% |
Perceptive Advisors | 1,075,216 | $53,503,000 | 2.04% |
PFM Health Sciences, LP | 1,538,131 | $75,153,000 | 2.00% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 997,000 | $48,713,000 | 1.95% |
HHLR ADVISORS, LTD. | 858,340 | $41,938,000 | 1.74% |